SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2017 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?


To: sjemmeri who wrote (341)2/5/2018 4:07:29 PM
From: A.J. Mullen1 Recommendation

Recommended By
Lance Bredvold

  Read Replies (1) | Respond to of 344
 
Biomaven's idea of using a Charitable Gift Account to anonymize donations looks better to me after receiving a couple of solicitations to ensure I was "remembered" at Stony Brook. I asked to be removed from Stony Brook's mailing list and received a friendly note from their Donations office, explaining I was on it because of my donation to the Thomas Hartman Center for Parkinson's Research. The lady responsible gave me permission to give her email. If anyone else wants to be off that list, send a note to remy.rubin@stonybrook.edu.

Ashley



To: sjemmeri who wrote (341)9/2/2018 10:56:23 AM
From: Robohogs2 Recommendations

Recommended By
A.J. Mullen
sjemmeri

  Respond to of 344
 
The 6 core losers from 2017 now up from 60K to 110-115k. The sub-ins only up from 40K to 45-50K. The big cap losers all solidly up, averaging 70% gains. The small cap guys all over with AFMD up 300% and ITEK 100%. The subbed-out list has 1 4x (XENE), 2 crashers and 1 even. xENE was down too much in 2017 tbh but still. Two that missed cut because not popular enough and not down enough anyway did badly. INCY highlights that group.